| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.54▼ | 6.57▼ | 6.54▼ | 6.37▲ | 5.12▲ |
| MA10 | 6.57▼ | 6.56▼ | 6.53▼ | 5.75▲ | 4.67▲ |
| MA20 | 6.56▼ | 6.50▲ | 6.42▲ | 5.00▲ | 4.20▲ |
| MA50 | 6.55▼ | 6.35▲ | 6.04▲ | 4.48▲ | 2.79▲ |
| MA100 | 6.44▲ | 5.79▲ | 5.25▲ | 3.98▲ | 2.66▲ |
| MA200 | 6.30▲ | 5.05▲ | 4.73▲ | 2.94▲ | 4.00▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.012▼ | -0.012▼ | -0.021▼ | 0.186▲ | 0.186▲ |
| RSI | 45.585▼ | 54.666▲ | 60.118▲ | 73.429▲ | 76.362▲ |
| STOCH | 18.672▼ | 58.156 | 63.648 | 92.622▲ | 74.059 |
| WILL %R | -53.659 | -59.574 | -34.146 | -6.273▲ | -4.942▲ |
| CCI | -88.425 | -66.132 | 28.905 | 94.976 | 258.564▲ |
|
Monday, February 16, 2026 03:33 AM
Key Insights Minerva Neurosciences' significant individual investors ownership suggests that the key decisions ...
|
|
Wednesday, February 04, 2026 07:19 AM
The following slide deck was published by Minerva Neurosciences, Inc. in conjunction with this event.
|
|
Tuesday, February 03, 2026 11:51 PM
Minerva Neurosciences (NASDAQ:NERV) hosted a virtual key opinion leader (KOL) event focused on its development candidate roluperidone for negative symptoms in schizophrenia, outlining the clinical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/02/26 | 6.425 | 6.63 | 6.425 | 6.52 | 43,937 |
| 17/02/26 | 6.29 | 6.69 | 6.09 | 6.45 | 135,339 |
| 13/02/26 | 6.29 | 6.40 | 6.21 | 6.27 | 67,300 |
| 12/02/26 | 6.22 | 6.35 | 6.00 | 6.29 | 64,100 |
| 11/02/26 | 6.34 | 6.39 | 5.86 | 6.33 | 115,692 |
| 10/02/26 | 5.65 | 6.47 | 5.61 | 6.31 | 219,747 |
| 09/02/26 | 4.79 | 5.85 | 4.71 | 5.65 | 301,500 |
| 06/02/26 | 4.29 | 4.91 | 4.13 | 4.80 | 78,026 |
| 05/02/26 | 4.56 | 4.73 | 4.19 | 4.22 | 105,485 |
| 04/02/26 | 4.85 | 4.8849 | 4.5001 | 4.67 | 66,479 |
|
|
||||
|
|
||||
|
|